2 results
Approved WMOCompleted
To validate the use of the Livv Mobiel ECG as a reliable office/bedside screening tool in primary care practice
Approved WMORecruiting
Primary(Part I and Part II):- To determine the maximum tolerated dose (MTD) and/or recommended Phase 2 dose (RP2D) in the QW and/or Q3W regimens of RO7122290 in combination with cibisatamab after pretreatment with obinutuzumab- To characterize theā¦